(Q40169711)

18 September 2017

1 reference

title

Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer (English)

1 reference

18 September 2017

Tumor interaction with hemostasis: The rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer (English)

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

8 October 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364802

8 October 2023

author name string

H. Al-Mondhiry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364802

8 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6364802

8 October 2023

publication date

1 February 1984

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fajh.2830160213

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.2830160213

8 October 2023

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

American Journal of Hematology

8 October 2023

published in

1 reference

18 September 2017

volume

16

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

193-202

1 reference

The role of blood platelets in experimental metastases

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJH.2830160213

Role of platelets in tumor cell metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJH.2830160213

Elevated Plasma <i>β</i>-Thromboglobulin Levels in Multiple Myeloma and in Polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJH.2830160213

Mechanism of lung tumour colony reduction caused by coumarin anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJH.2830160213

Incidence and clinical significance of tumor embolization to the lungs

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Localization of intracranial tumors.Comparative study with131I-labeled antibody to human fibrinogen and neohydrin-203Hg

8 October 2023

8

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Journal of the National Cancer Institute

8 October 2023

10

46

493

Jones

1971

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

131I-labeled antibodies to human fibrinogen.Diagnostic studies and therapeutic trials

8 October 2023

11

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Microangiopathic Haemolytic Anaemia and Experimental Tumour-Cell Emboli

8 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Platelet and fibrinogen consumption in man.

8 October 2023

13

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Fibrinogen survival and fibrinolysis in acute leukemia

8 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Removal of sialic acid from the cell coat in tumor cells and vascular endothelium, and its effects on metastasis

8 October 2023

21

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Antimetastatic effects associated with platelet reduction

8 October 2023

22

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

8 October 2023

23

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line

8 October 2023

25

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential

8 October 2023

27

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells

8 October 2023

28

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Prostacyclin: a potent antimetastatic agent

8 October 2023

29

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Calcium as a regulator of the proliferation of normal, but not of transformed, chicken fibroblasts in a plasma-containing medium

8 October 2023

31

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Platelets as a source of fibroblast growth-promoting activity.

8 October 2023

32

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro

8 October 2023

33

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Beta-thromboglobulin and platelet-factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy

8 October 2023

36

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo

8 October 2023

37

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Anti-metastatic effect of aspirin

8 October 2023

39

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL)

8 October 2023

42

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids

8 October 2023

45

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Tumors, mucus production, and hypercoagulability

8 October 2023

49

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Cancer procoagulant A: A factor X activating procoagulant from malignant tissue

8 October 2023

50

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Tissue factor-like activity of the human monocytic tumor cell line U937

8 October 2023

53

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Clot forming and clot stabilizing enzymes from the mouse tumor YPC-1

8 October 2023

54

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Enhancement of Pulmonary Metastases following the Intravenous Infusion of a Suspension of Ellagic Acid

8 October 2023

56

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells

8 October 2023

58

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Rationale and experimental design for the va cooperative study of anticoagulation (warfarin) in the treatment of cancer

8 October 2023

59

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants

8 October 2023

61

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

8 October 2023

62

3

174

Williams

1972

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Osteosarcoma.Improved Survival with Anticoagulation and Amputation

8 October 2023

63

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Increasing the efficiency of cancer chemotherapy with heparin: "clinical study".

8 October 2023

65

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

Heparin and chemotherapy in the management of inoperable lung carcinoma

8 October 2023

66

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

8 October 2023

Cancer Treatment Reports

67

60

575

Edlis

1976

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

8 October 2023

Cancer Treatment Reports

68

61

1399

Rohwedder

1977

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells

8 October 2023

70

1 reference

https://api.crossref.org/works/10.1002/AJH.2830160213

8 October 2023

Identifiers

1 reference

18 September 2017

1 reference